Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Welman Pharmaceuticals is a Nigerian pharmaceutical company established in 2006 that specializes in the marketing, distribution, and manufacturing of high-quality branded generic medicines. Headquartered in Lagos, the company's portfolio spans several therapeutic areas, including anti-infectives, cardiovascular health, antimalarials, and metabolic disorders. Welman is committed to providing affordable healthcare solutions across Nigeria and the West African sub-region. Their product line includes well-known brands such as Welmox, Welcip, and Welmet, catering to both acute and chronic conditions. The company operates as a private entity and is a significant player in the Nigerian pharmaceutical industry. Welman maintains a strong focus on quality assurance and regulatory compliance to ensure the safety and efficacy of its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WELMAN Pharmaceutical.